Welcome to our dedicated page for RIWI news (Ticker: $RWCRF), a resource for investors and traders seeking the latest updates and insights on RIWI stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RIWI's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RIWI's position in the market.
RIWI Corp. (TSXV: RIWI, OTC PINK: RWCRF) announced its Q1 2024 financial results. The company recorded $1,135,847 in revenue, a 5.4% decrease from Q1 2023. Net income was $27,087, compared to a net loss of $127,944 in the same period last year. Operating expenses reduced significantly to $1.14M from $1.35M.
RIWI acquired CoolTool Inc.'s assets and has begun integrating its platform, expecting initial deals to close in Q2 2024. The company signed 19 new contracts and onboarded 8 new clients. Investments in marketing and data quality improvements were highlighted. RIWI's management anticipates consistent profitability within the 2024 fiscal year.
RIWI Corp. granted 544,936 stock options to executives at CAD $0.75 per share, expiring in 2029.